Pharma Focus Europe

LATEST NEWSRead more...

19

Jul 2024

Meitheal Pharmaceuticals Expands Its Specialty Biopharma Range by Acquiring CONTEPO™ (Fosfomycin for Injection) from Nabriva Therapeutics

Meitheal Pharmaceuticals Inc a biopharmaceutical company based in Chicago with a focus on generic injectables fertility treatments biologics and branded products has announced its acquisition

19

Jul 2024

NMDP BioTherapies and the Cord Blood Bank Alliance Announce Enhanced Selection of Cord Blood Units for NK and Other Cell Therapies

NMDP BioTherapiesSM and the NMDP BioTherapies Cord Blood Bank Alliance which includes nine public cord blood banks are now providing preidentified cord blood units

18

Jul 2024

Draupnir Bio Raises €12 Million in Seed Funding to Further Develop Oral Small Molecule Degraders Targeting Extracellular Proteins

Draupnir Bio a biotechnology company has raised million in equity investments to advance its innovative approach in targeted protein degradation The company focuses on developing oral

18

Jul 2024

Grünenthal Increases Investment in Latin America Production Facilities to Ensure Reliable Medicine Supply

Grnenthal a leading pharmaceutical company specializing in pain research and management has recently announced significant investments in its Latin American production sites These investments

17

Jul 2024

Genomics plc and Vertex Pharmaceuticals Extend and Expand Collaboration in Drug Discovery

Genomics plc has announced a further threeyear extension of its collaboration with Vertex Pharmaceuticals Incorporated to advance the discovery and development of precision medicines

17

Jul 2024

Synamics Therapeutics Attracts Former Executives from Novozymes as Lead Investors for AI-Driven Drug Discovery

Synamics Therapeutics a startup focused on using AI for drug discovery to combat drug resistance in cancer has received significant backing in its preseed funding round from two prominent figures

press releasesRead more...

Bristol Myers Squibb Receives European Medicines Agency Validation of Application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Unresectable

Bristol Myers Squibb today announced that the European Medicines Agency validated its Type II variation application for Opdivo plus Yervoy as a potential

Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in Spinal Cord Injury

Synaptogenix Inc an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders today announced a new

Bioxytran Launches Joint Venture with the Heme Foundation for Development of Universal Oxygen Carrier

BIOXYTRAN INC a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID other viral diseases and stroke is pleased to announce a Joint Venture with the Heme Foundation

Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15

Silo Pharma Inc a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments today announced

18 - 20

Jul 2024

Pharma India Expo 2024

Telangana, India

29 - 31

Jul 2024

16 - 17

Aug 2024

iPharma Expo 2024

Boston, USA

21 - 22

Aug 2024

22 - 24

Aug 2024

22 - 24

Aug 2024
Thermo Fisher Scientific - mRNA Services
World Orphan Drug Congress 2024
World Vaccine Congress Europe 2024
Advanced Therapies USA 2024
cytiva

TOP ARTICLES

  • 1

    The Impact of Digital Health Technologies on Patient Outcomes

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 2

    How Drug Patents Shape the Competitive Landscape in Pharma?

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 3

    Pharmaceutical Marketing in the Digital Age: Strategies and Challenges

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 4

    The Role of Technology in Enhancing Patient Acceptance and Satisfaction

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 5

    Innovative Solutions: Cell and Gene Therapy's Impact on Pharma

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

KNOWLEDGE BANK

EDITORIAL SECTION